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http://dx.doi.org/10.1016/j.kjms.201
1607-551X/Copyright ª 2014, KaohsiuAbstract The purpose of this study is to investigate the effect of thyroid eye disease (TED) on
the measurement of corneal biomechanical properties and the relationship between these pa-
rameters and disease manifestations. A total of 54 eyes of 27 individuals with TED and 52 eyes
of 30 healthy control participants were enrolled. Thyroid ophthalmopathy activity was defined
using the VISA (vision, inflammation, strabismus, and appearance/exposure) classification for
TED. The intraocular pressure (IOP) measurement with Goldmann applanation tonometer
(GAT), axial length (AL), keratometry, and central corneal thickness (CCT) measurements were
taken from each patient. Corneal biomechanical properties, including corneal hysteresis (CH)
and corneal resistance factor (CRF) and noncontact IOP measurements, Goldmann-correlated
IOP (IOPg) and corneal-compensated IOP (IOPcc) were measured with the Ocular Response
Analyzer (ORA) using the standard technique. Parameters such as best corrected visual acuity,
axial length, central corneal thickness, and corneal curvature were not statistically significant
between the two groups (p > 0.05). IOP measured with GATwas higher in participants with TED
(p < 0.001). The CH of TED patients was significantly lower than that of the control group.
There was no significant difference in the corneal resistance factor between groups. However,
IOPg and IOPcc were significantly higher in TED patients. CH and VISA grading of TED patients
showed a negative correlation (pZ 0.007). In conclusion, TED affects the corneal biomechan-
ical properties by decreasing CH. IOP with GAT and IOPg is found to be increased in these pa-
tients. As the severity of TED increases, CH decreases in these patients.
Copyright ª 2014, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.eclare no conflicts of interest.
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Thyroid eye disease (TED) is an inflammatory and autoim-
mune expression of Graves’ disease causing functional and
cosmetic problems. The clinical manifestations of TED are
periorbital edema, increase in orbital volume which may
lead to increase in intraorbital pressure, conjunctival hy-
peremia and chemosis, proptosis, restrictive myopathy
leading to strabismus and/or diplopia, eyelid retraction,
exposure keratopathy, lagophthalmus, and compressive
optic neuropathy [1,2].
The alterations in the ocular surface due to increased
palpebral fissure width, increased blink rate, lagoph-
thalmus, and lid lag in TED patients resulting in hypo-
secretory and evaporative mechanism, modify the tear film
and leads to dry eye syndrome [3,4]. The increase in tear
film osmolarity in patients with TED is also related to
increased proptosis and palpebral fissure width [4e6]. Vil-
lani et al [3] demonstrated that the significant reduction in
surface epithelial cell density is due to the damaged ocular
surface, increase in the number of basal epithelial cells
owing to a proliferative stimulus, and the increase in acti-
vated keratocytes and dendritic cells as a sign of
inflammation with confocal microscopy in Graves’ oph-
thalmopathy. They also showed that the number of nerves
was reduced, and the tortuosity of the nerve fibers and the
number of beadlike formations were increased.
The cornea is not purely elastic but rather viscoelastic,
which means that the rate at which a load is applied
changes the measured value for the Young modulus [7,8].
In vivo corneal biomechanical evaluation was first intro-
duced by Luce [9] using the Ocular Response Analyzer (ORA;
Reichert Ophthalmic Instruments, Depew, NY, USA). This
instrument measures the corneal biomechanical properties
as corneal hysteresis (CH) and corneal resistance factor
(CRF), and determines the noncontact intraocular pressures
(IOP) as Goldmann-correlated IOP (IOPg) and corneal-
compensated IOP (IOPcc) [9e11]. The ORA evaluates
corneal response to indentation by a rapid air pulse using an
infrared light to measure applanation of the cornea. The air
pulse results in an inward, and concave state of cornea. As
the air pressure decreases, the cornea passes back through
the applanation and moves outward. It provides two
applanation measurements and pressures within 20 milli-
seconds: one when the cornea is flat on the way in (P1) andFigure 1. Corneal hysteresis is the difference between “in-
ward” and “outward” applanation pressures.the other on the way out (P2) (Fig. 1) [12]. The difference
between two pressures is CH, reflecting corneal viscoelas-
ticity. CRF is calculated from the formula (P1 e kP2), where
k is a constant. The constant k is determined from an
empirical analysis of the relationship between both P1 and
P2 and the central corneal thickness (CCT) to develop a
parameter more strongly associated with CCT than CH [13].
CRF is thought to represent the overall resistance and the
elastic properties of the cornea. IOPg is the average of two
pressure measurements, which is intended to correspond to
the Goldmann applanation tonometer (GAT). IOPcc is a
pressure measurement that is said to be compensated for
corneal properties, and uses information provided by CH
measurement to obtain an IOP that is less affected by CCT
and corneal curvature [8,9].
In recent years, evidence suggests that the biomechan-
ical properties of the cornea are altered in glaucomatous
eyes [10,14e16], keratoconic corneas [17e19], myopic eyes
[13,20,21], in eyes of individuals with diabetes mellitus
[11,22] and systemic lupus erythematosus [23], in post-
laser in situ keratomileusis eyes [24,25], and in eyes
following penetrating keratoplasty [26]. The aim of this
study was to investigate biomechanical parameters of the
cornea measured with ORA in TED, and the relationship
between these parameters and disease manifestations.Methods
A total of 54 eyes of 27 patients who were admitted to the
oculoplastic and reconstructive surgery department
because of TED and 52 healthy eyes of 30 control in-
dividuals were enrolled in this observational comparative
study in Beyoglu Eye Training and Research Hospital,
Istanbul, Turkey between January 2011 and June 2011.
Informed consent was obtained from all participants. The
study followed the tenets of the Declaration of Helsinki and
was approved by the local ethics committee.
Exclusion criteria consisted of glaucoma, diabetes, his-
tory of ocular surgery or trauma, use of any topical medi-
cation, contact lens wear, and high refractive error or
corneal abnormalities such as keratoconus and corneal
dystrophy, which may affect measurement.
Diagnosis of TED was based on the criteria of the Euro-
pean Group on Graves’ Orbitopathy Consensus Statement
[27,28]. Thyroid ophthalmopathy activity was defined by
using the VISA classification for TED [29]. This classification
system is based on four disease end points: vision, inflam-
mation, strabismus, and appearance/exposure. Each sec-
tion records subjective and measurable objective inputs
and plans ancillary testing. The goal of the vision section is
described as to rule out optic neuropathy. Details on vision
loss and color change were asked from TED patients as
subjective measurements. Best corrected visual acuity
(BCVA; using Snellen chart), color vision (using Ishihara
plates), pupil response, and the appearance of optic nerve
head were used as objective tests for vision. Ancillary
testing included Standard Automated Perimetry with the
Humphrey Field Analyzer (Carl Zeiss Meditec, Dublin, CA,
USA) using the 30-2 SITA Standard program as well as
computed tomography or magnetic resonance imaging
scans to confirm crowding of orbital apex and extraocular
Table 1 Comparison of clinical findings for patients with
thyroid eye disease and healthy control participants.
Mean Patients with
TED (n Z 54)
Healthy control
participants
p
Corneal biomechanics in thyroid eye disease 301muscle involvements and visual evoked potential. As a
result of the vision section, we were able to record whether
optic neuropathy is present or absent. The inflammatory
score included orbital pain at rest or with gaze, chemosis,
eyelid edema, conjunctival injection, and eyelid injection.
For evaluating strabismus symptoms, we looked for corneal
light reflex, using the Hirschberg principle, and made prism
cover testing (measured in prism diopters) in different gaze
directions. Eyelid retraction (measured in millimeters),
proptosis (measured with the Hertel exophthalmometer),
presentation of redundant skin, fat prolapse, and corneal
staining were documented for appearance grading. Because
none of the patients in the TED group had optic neuropathy
and management of the disease is based on inflammatory
score and evidence of progression [29], we used the VISA
inflammatory score in grading patients. In addition, pho-
tographs of patients at nine cardinal gaze positions and
with eyelids closed were taken with the same camera and
by the same technician.
Each participant underwent IOP measurement with GAT.
Axial length (AL) and keratometry measurements were
performed with IOL Master optical biometry (Zeiss Meditec
AG, Jena, Germany). CCT was measured with ultrasono-
graphic pachymetry (DGH-550, DGH Technology Inc., Exton,
PA, USA).
Corneal biomechanical properties, including CH, CRF,
IOPg, and IOPcc, were always measured by ORA using the
standard technique [13,30,31]. All ORA measurements were
obtained using the same calibrated instrument by the same
masked technician. All patients underwent measurement
while sitting and asked to fixate on a target light as the
measurement was taken. A noncontact probe scanned the
central corneal area and released an air puff. For each
patient, three measurements were obtained; the reading
with the best signal value was used in the statistical eval-
uation. CCT measurement was performed with an ultra-
sonic pachymeter by another experienced technician.
Three replicate measurements were obtained, and the
mean values of the measurements were accepted.
All statistical analyses were performed with SPSS for
Windows version 16.0 (SPSS Inc., Chicago, IL, USA). The
parameters of groups were compared using Student t test
and one-way analysis of variance. The correlations between
parameters were evaluated with the Pearson’s correlation
coefficient. A p value of < 0.05 was considered statistically
significant.
We certify that all applicable institutional and govern-
mental regulations concerning the ethical use of human
volunteers were followed during this research.(n Z 52)
Age (y) 46.3  11.7 46.8  11.6 0.81
BCVA (Snellen) 0.963 0.967 0.83
Axial length (mm) 23.03 23.31 0.44
CCT (mm) 550.87 550.77 0.99
Keratometry
(diopter)
43.89 44.28 0.99
IOP-GAT (mmHg) 16.61 13.84 <0.001*
*Statistically significant.
BCVA Z best corrected visual acuity; CCT Z central corneal
thickness; IOP-GAT Z intraocular pressure measured by Gold-
mann applanation tonometry; TED Z thyroid eye disease.Results
The study included 54 eyes of 27 participants (24 female, 3
male) with TED as Group 1 and 52 healthy eyes of 30 control
participants (17 female, 13 male) as Group 2 (p Z 0.001).
The mean  SD age of patients was 46.3  11.7 years (range
21e70 years) and 46.8  11.6 years (range 20e69 years) for
Group 1 and Group 2, respectively (p > 0.05). The mean
duration of thyroid disease was 5.85  4.76 years.
The parameters such as BCVA, AL, CCT, and corneal
curvature were not statistically significant between groups(p > 0.05; Table 1). The IOP measured with GAT was higher
in patients with TED (p < 0.001).
CH was significantly lower in Group 1 than in Group 2.
There was no significant difference in CRF between the two
groups. However, IOPg and IOPcc were significantly higher in
Group 1 (Table 2). There was a positive correlation between
GAT IOP readings and IOPg and IOPcc measured by ORA
(Pearson correlation analyses, p < 0.0001).
When the patients with TED were classified according to
VISA classification for TED activity, there was no significant
difference in terms of ORA parameters between the sub-
groups. However, in correlation analysis, CH and VISA
grading of TED patients showed a negative correlation
although not at a significant level (p Z 0.007; Fig. 2).
However, there was a significant difference in CCT among
grades 0 and 6 (p Z 0.019) as well as in grades 4 and 6
(p Z 0.006; one-way analysis of variance test). The distri-
bution of the mean ORA parameters and CCT according to
VISA classification is shown in Table 3.
To increase confidence of our study, in addition to the
groups mentioned above, two groups were created
including only one eye of the participants. We randomly
enrolled only one eye of the patients with TED to the study
group, which consisted of 27 eyes (24 female, 3 male), and
compared it with our control group, which consisted of 26
eyes (17 female, 9 male). The age, BCVA, AL, CCT, and
corneal curvature were not statistically significant between
the two groups (p > 0.05). The IOP measured with GAT was
significantly higher in the TED group (p Z 0.01). CH was
significantly lower; however, IOPg and IOPcc were signifi-
cantly higher in the TED group (p Z 0.025, p Z 0.007, and
p Z 0.01, respectively). There was no statistically signifi-
cant difference in CRF between the groups (p Z 0.86).
These results were correlated with the results of our pre-
vious groups included in this study.Discussion
Tissue response and deformation when placed under stress
is determined by biomechanical properties of the tissue.
The measurement with ORA is a direct, noninvasive, and
Table 2 Comparison of ORA parameters of the two
groups.
ORA parameters Patients with
TED (n Z 54)
Control
participants
(n Z 52)
p
Corneal hysteresis 10.01 10.77 0.009*
Corneal resistance
factor
10.85 10.75 0.76
Goldmann-correlated
IOP
17.93 15.56 0.002*
Corneal-compensated
IOP
18.5 15.62 <0.001*
IOP Z intraocular pressure; ORA Z Ocular Response Analyzer;
TED Z thyroid eye disease.
Figure 2. Correlation between corneal hysteresis (CH) and
VISA classification.
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biomechanics. Beside the structural and functional effects
of TED on corneal properties, we wanted to evaluate the
effect of TED on corneal biomechanical propertiesTable 3 Distribution of the mean ocular response analyzer p
classification.
VISA grading Number of
patients
Corneal
hysteresis
Corneal
resistance factor
Cor
0 20 10.55 11.48
1 10 10.29 10.51
2 11 9.38 10.43
3 2 10.05 11
4 5 10.54 11.32
6 2 8.10 8.15
7 2 9.10 11.2
11 2 8.35 9.65
p 0.39 0.286
IOP Z intraocular pressure.measured via ORA and the relationship between these pa-
rameters and TED manifestations.
In this study, we found that the CH of TED patients was
significantly lower than that of the healthy control group
(Table 2). CH is a measurement of corneal viscoelasticity.
Elasticity is the continuum mechanics of bodies that deform
reversibly under stress and is directly proportional to the
force applied [30]. Viscosity is the tendency of liquids to
resist flow so that after deformation by stress, they do not
regain their original shape [17]. While recovering to the
original shape, the relaxation path is found to be different
from the deformation path, which is called hysteresis [17].
CH is the dynamic response of the cornea reflecting the
capacity of the corneal tissue to absorb and dissipate en-
ergy [9]. Low values of CH are often described to indicate a
“soft” or “floppy” cornea [32] and less corneal viscous
dampening. The dampening effects of the cornea decrease
in diseases such as keratoconus [17e19], glaucoma
[10,14e16], Fuchs’ dystrophy [9], myopic eyes [13,20,21],
in eyes with diabetes mellitus [11,22] and systemic lupus
erythematosus [23], in post-laser in situ keratomileusis
[24,25] eyes, and in eyes following penetrating keratoplasty
[26]. Lower CH, described as a decrease in the dampening
effects of the cornea, may be explained by an alteration in
the corneal structure and functional problems resulting
especially in dry eye in TED. In other words, the corneas of
patients with TED may have similar alterations in the
corneal microstructure known to occur in these corneal
diseases. However, the CRF of TED patients was not
significantly different from that of control participants
(Table 2). CRF is thought to be a correction factor that
reduces the effect of CCT on IOP measurements [9] and is a
parameter more strongly associated with CCT than CH [13].
Because CCT measurements showed no statistical differ-
ences in Group 1 and Group 2, CRF may not differ between
groups. This means that the elastic property of the cornea
that appears to be an indicator of the overall “resistance”
of the cornea does not change in TED. This study is a pre-
liminary report, and further research is needed to elucidate
this matter. We also enrolled only one eye of the study
patients and the control group and compared all parame-
ters. We found similar results with our previous groups
included in this study.arameters and central corneal thickness according to VISA
neal-compensated
IOP
Goldmann-correlated
IOP
Central corneal
thickness
(mm)
18.5 18.6 560.3
16.6 16.1 542.8
19.1 17.9 541.2
19.0 18.4 539.5
17.9 18.0 587.0
17.6 14.5 457.5
23.0 21.9 564.0
21.1 18.9 551.0
0.584 0.452 0.772
Corneal biomechanics in thyroid eye disease 303As documented by several studies, GAT measurements
can be affected by several ocular properties such as CCT,
AL, and corneal curvature [14,33,34]. It has been found
that the difference in thickness ranged from 9% to 52%
greater for peripheral cornea in addition to describing the
relationship between IOP and CCT [34]. Konuk et al [35]
also investigated CCT alterations in Graves’ disease and
Graves’ ophthalmopathy cases according to the disease
severity and hormonal status of the patients and healthy
control participants. They found that the CCT values of
patients with Graves’ disease and patients with Graves’
ophthalmopathy with hyperthyroid and euthyroid hormonal
status showed no statistical difference among themselves
and versus control participants. In our study, CCT was not
statistically significantly different between Group 1 or
Group 2. ORA may provide additional factors over CCT to
help with the assessment of the accuracy of IOP measure-
ment [13].
Corneal curvature is another variable that can affect
GAT measurements [33]. More force must be applied
against a steep than a flat cornea, increasing the indicated
value of the IOP. In this study, it is found that ocular bio-
metric measurements such as AL and corneal curvature
were also not significantly different between groups.
There was a statistically significant difference in the
ratio of female and male cases between our control and
study groups, but sex bias had no effect on the results of
ORA parameters. In the study of Shah et al [18], no corre-
lation was found between hysteresis in males and females.
Wells et al [36] investigated the corneal biomechanical
properties in glaucoma patients and reported a strong sex
bias toward male patients in the glaucoma study group,
which had a tangible influence on the results. In the study
of Ortiz et al [24], no difference in biomechanical proper-
ties was observed between men and women, suggesting
that it is not necessary to sex-match the patients.
An increase in IOP in upward gaze is regarded as a
restrictive ocular motility disorder owing to the compres-
sion of globe [37]. All measurements including GAT and ORA
were taken in the primary position of gaze in all patients.
Although we eliminated the variables affecting the IOP
measurements between groups, we found that GAT IOP
measurements, IOPcc, and IOPg were higher in TED patients.
Compression of globe due to extraocular muscle involve-
ment with or without restrictive myopathy and biome-
chanical properties changing with corneal microstructure
and functional problems may have an impact on IOP
measurement.
Dolman and Rootman [29] pointed out that research
studies can be facilitated by using VISA classification, which
helps direct the appropriate management of patients with
TED in a logical sequence. We used this classification and
searched whether corneal biomechanical properties change
according to disease severity. In our study, it is found that
none of the ORA parameters significantly correlated with
VISA grading. However, there was a negative correlation
between CH and VISA grading. Although our study may be
accepted as a preliminary report, it may be indicated that
corneal biomechanical properties do not change with the
disease severity.
In conclusion, TED affects corneal biomechanical prop-
erties by decreasing CH, indicating that the structural,functional, and biomechanical properties of the cornea
may be different in eyes with TED than in control eyes. IOP
measurement with GAT, IOPcc, and IOPg is found to be
increased in these patients. Although there was no statis-
tically significant difference between ORA parameters in
subgroups according to VISA classification, there was a
negative correlation between CH, and so with corneal
viscoelasticity and disease severity. This study is the first
report to investigate the corneal biomechanics in TED.
Further studies with larger numbers of participants are
necessary to establish the relevance and usefulness of
biomechanical measurements in TED.References
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